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Abstract
Background: Chronic kidney disease (CKD) is common in geriatric cats, and the most prevalent pathology is
chronic tubulointerstitial inflammation and fibrosis. The cell type predominantly responsible for the production of
extra-cellular matrix in renal fibrosis is the myofibroblast, and fibroblast to myofibroblast differentiation is probably a
crucial event. The cytokine TGF-β1 is reportedly the most important regulator of myofibroblastic differentiation in
other species. The aim of this study was to isolate and characterise renal fibroblasts from cadaverous kidney tissue
of cats with and without CKD, and to investigate the transcriptional response to TGF-β1.
Results: Cortical fibroblast cultures were successfully established from the kidney tissue of cats with normal kidney
function (FCF) and cats with chronic kidney disease (CKD-FCF). Both cell types expressed the mesenchymal markers
vimentin, CD44 and CD29, and were negative for the epithelial marker cytokeratin, mesangial cell marker desmin
and endothelial cell marker vWF. Only CKD-FCF expressed VCAM-1, a cell marker associated with inflammation.
Incubation with TGF-β1 (0–10 ng/ml) induced a concentration dependent change in cell morphology, and
upregulation of myofibroblast marker gene α-SMA expression alongside collagen 1α1, fibronectin, TGF-β1 and CTGF
mRNA. These changes were blocked by the TGF-β1 receptor 1 antagonist SB431542 (5 μM).
Conclusions: FCF and CKD-FCF can be cultured via a simple method and represent a model for the investigation of the
progression of fibrosis in feline CKD. The findings of this study suggest TGF-β1 may be involved in fibroblast-myofibroblast
transition in feline CKD, as in other species.
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Background
Chronic kidney disease (CKD) is common in geriatric
cats, with a reported prevalence of 28–50% [1, 2]. The
majority of cats with CKD are found to have non-
specific renal lesions and the predominant morpho-
logical diagnosis in these cases is chronic tubulointersti-
tial inflammation and fibrosis [3, 4]. Whilst fibrosis is a
normal sequelae of injury, it is thought that in CKD the
normal wound healing response fails to terminate [5, 6]
and the expansion of the extra-cellular matrix (ECM)
gradually destroys normal tissue structure [7]. The com-
position of the aberrant ECM in cats with CKD has not
been well defined, but both collagen I and fibronectin
have been shown to be upregulated in the diseased renal
interstitium [8, 9].
In the normal kidney, the dominant cell type respon-
sible for ECM homeostasis is the interstitial fibroblast
[10]. Interstitial fibroblasts play an important role in the
synthesis and degradation of extra-cellular matrix as well
as an endocrine role as producers of erythropoietin [11]
and, under certain conditions, renin [12]. Additionally,
fibroblasts play an important role in maintaining the
integrity of the renal vasculature. In renal fibrosis the
major ECM producing cell is the myofibroblast, a cell
type which possesses both fibroblastic and smooth
muscle cell characteristics [13, 14]. Although the origin
of these cells has previously been controversial, they are
now believed to originate primarily from resident fibro-
blasts [14]. The morphological features differentiating a
myofibroblast from a fibroblast are only apparent on
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electron microscopy and expression of the contractile
protein α-SMA is the most widely used marker of myofi-
broblast differentiation. Interstitial α-SMA expression in
cats is reported to appear early in the pathogenesis of
CKD and is correlated with severity of fibrosis and
serum creatinine [8, 15].
The induction and proliferation of myofibroblasts is
probably a crucial event in the initiation and progression
of renal fibrosis, and may be regulated by a number of
local and circulating factors. These include paracrine
fibroblast growth factors (FGFs), platelet-derived growth
factor (PDGF), angiotensin II, aldosterone and, most im-
portantly, transforming growth factor β1 (TGF-β1) and
connective tissue growth factor (CTGF) [16]. TGF-β1 is
a pro-fibrotic cytokine thought to be the primary medi-
ator driving the progression of interstitial fibrosis in
chronic kidney disease, which has led to its description
as the “master regulator of fibrosis” [17]. TGF-β1
directly stimulates transcription of ECM, as well as me-
diating effects via downstream activation of the matricel-
lular protein connective tissue growth factor (CTGF)
[18, 19]. Increased urinary TGF-β1 excretion is associ-
ated with interstitial fibrosis in cats [20], suggesting this
cytokine may play a causative role in the development of
fibrosis as in other species. However, whether TGF-β1
has analogous effects on feline renal fibroblasts at a
cellular level is unknown.
Cultures of renal fibroblasts are recognised as an import-
ant tool for understanding the fibroblast-myofibroblast
transition and regulation of ECM production in renal fibro-
sis [21]. However, there are currently no published studies
detailing a methodology for the culture of feline fibroblasts,
or examining the effects of pro-fibrotic mediators such as
TGF-β1 on these cells. The aims of this study were to:
i) Isolate and characterise renal cortical fibroblasts
from the cadaverous renal tissue of cats with normal
renal function and cats with CKD
ii) Determine the effect of TGF-β1 on mRNA expression
of genes associated with activation and differentiation
towards myofibroblast phenotype in cortical
fibroblasts isolated from cats with chronic kidney
disease (CKD-FCF)
Methods
Cell culture
Kidneys were obtained from three cats with CKD and
two cats with normal renal function recently (< 2 h)
euthanased for welfare reasons, with owner informed
consent. Cats were diagnosed with CKD based upon
history, physical examination and a plasma creatinine
concentration > 177 μmol/L with concurrent urine
specific gravity < 1.035. Cats were considered to have
normal kidney function in the absence of any historical
or physical examination findings suggest of kidney
disease, and if plasma creatinine was < 177 μmol/L with
appropriately concentrated urine.
The renal cortex was minced and dissociated by incu-
bating in Dulbecco’s modified Eagle medium: Nutrient
mixture F-12 (DMEM/F12) containing 1 mg/ml collage-
nase (collagenase A from clostridium hemolyticum,
Roche) for 25 min at 37 °C in a water bath. The digested
tissue was centrifuged for 3 min at 90 x g, resuspended
in DMEM/F12 and passed through a 212-μm sieve set
on top of a 106-μm sieve into a 100 mm tissue culture
dish. The sieved cells were centrifuged for 3 min at 90 x g
and resuspended in 10 ml DMEM/F12. The resuspended
mixture was left to settle for 10 min, and the supernatant
removed in order to remove residual red blood cells. The
remaining pellet was resuspended in DMEM/F12 contain-
ing 10% foetal bovine serum (FBS) and 1% penicillin-
streptomycin (Thermofisher scientific) and transferred
into a 75cm2 tissue culture flask (Nunclon™ delta surface).
Cells were maintained at 37 °C in a 5% CO2/95% air hu-
midified incubator (BB15 CO2; Thermofisher scientific).
After 24 h the medium was removed and the cells gently
washed with Dulbecco’s phosphate buffered saline (DPBS;
Life technologies) before replacement of fresh primary cul-
ture medium. Thereafter, culture medium was replaced
every 48 h. Once 75–80% confluent, the cells were trypsi-
nized and distributed into tissue culture flasks/plates at a 1:3
subculture ratio. For experimental use, cells were cultured
in reduced serum medium containing 3% FBS. All experi-
ments were performed using cells from passages 1 or 2.
Immunofluorescent detection of proteins in isolated cells
Cells were assessed for the expression of the marker
proteins cytokeratin AE1/AE3, vimentin, desmin, von
Willebrand factor, CD44, CD29 and VCAM-1 by
immunofluorescence. Cells were plated onto collagen I
coated glass bottomed chamber slides (Nunc Lab-tek II
chamber slide™, Sigma-Aldrich), left to adhere, then
fixed in 4% formaldehyde for 15 min. Fixed cells were in-
cubated with 50 mM ammonium chloride (Sigma-Aldrich)
for 15 min, washed three times with tris-buffered saline
(TBS) and permeabilized with 0.1% triton in TBS. Cells
were incubated in blocking buffer (3% BSA, 1% goat serum,
0.1% tween in TBS) for 2 h at room temperature, then
incubated with the desired primary antibody diluted in
blocking reagent for 1 h at room temperature. Details of
the primary antibodies used are provided in Table 1. After
three washes with TBS, labelled cells were incubated with
the respective fluorescent secondary antibody (1:1000 in
blocking reagent) for 1 h in the dark. After three further
washes with TBS pH 7.4, the chambers were removed and
a coverslip mounted using Fluoroshield™ with DAPI
(Sigma-Aldrich). Images were collected using a DM4000B
upright microscope with samples illuminated using an
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EBQ100 light source and filter cubes A4, L5 and TX2 (all
from Leica Microsystems, Milton Keynes, UK) and an
AxioCam MRm monochrome camera controlled through
Axiovision software version 4.8.2 (Carl Zeiss Ltd.,
Cambridge, UK). Each experimental repeat included an
isotype control matched to the species and isotype of the
primary antibody used. Experiments were carried out in
triplicate for the CKD-FCF and duplicate for the FCF.
Western blotting
Confluent monolayers of CKD-FCF were washed with
ice cold DPBS, containing 0.4 mM sodium orthovana-
date (Sigma-Aldrich), before lysis in 68.3 mM Tris-HCl
(Sigma-Aldrich) containing 10% (w/v) glycerol (Sigma-
Aldrich), 2% (w/v) sodium dodecyl sulphate (SDS;
Sigma-Aldrich), 2 mM sodium orthovanadate, 10 μl/ml
protease inhibitor cocktail (Sigma-Aldrich). Proteins
(25 μg) were separated by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) using pre-
cast gels (10% Mini-protean TGX Stain-Free™ protein
gel, Bio-rad), before transfer onto a polyvinylidene
difluoride (PVDF) membrane (0.45 μm pore, Hybond™;
GE Healthcare). Membranes were blocked for 3 h at
room temperature in 5% (w/v) milk (Marvel) made up in
Tris-buffered saline with Tween (TBST; 50 mM Tris,
150 mM NaCl, 0.02% (v/v) Tween 20, pH 7.4). For
immunodetection of proteins of interest, membranes
were incubated overnight at 4 °C with primary antibody
diluted in TBST + 10% (w/v) BSA containing anti-
vimentin (1:1000), anti-cytokeratin AE1/AE3 (1:1000),
anti-vWF (1:1000), anti-CD29 (1:500), or anti-β-actin
(1:5000) antibody. Subsequent to this, membranes were
washed in TBST (6 × 10 min) and then incubated with
horse radish peroxidase (HRP) conjugated goat anti-
rabbit/mouse IgG as appropriate (1:10,000) in TBST
containing 0.2% (w/v) BSA for 1 h at room temperature.
After further washing (6 × 10 min), immunoreactive
bands were detected via enhanced chemiluminescence
(ECL). This was performed by exposing the blots to
0.1 M Tris pH 8.5 containing 0.25 mg/ml luminol
(Sigma-Aldrich), 0.18 mg/ml 4-iodophenol (Sigma-Aldrich),
0.01% (v/v) H2O2 (Sigma-Aldrich) for 1 min, and visualising
bands using photographic film (Hyperfilm™, Kodak).
Experiments were carried out in triplicate, where each
experimental repeat represented a separate isolation
from an individual cat.
Evaluation of cell morphology after incubation with TGF-β1
CKD-FCF were incubated for 72 h in six-well tissue culture
plates (Nunclon™ delta surface) in the presence of vehicle,
0.1–10 ng/ml human recombinant TGF-β1 (rTGF-β1) or
10 ng/ml rTGF-β1 plus the TGF-β1 receptor 1 (TGF-β1R1)
antagonist SB431542 (5 μM). Images of the incubated cells
were collected using a DMIRB inverted microscope with
samples illuminated using an EBQ100 light source (Leica
Microsystems, Milton Keynes, UK) and an AxioCam ICm1
monochrome camera controlled through Axiovision
software version 4.8.2 (Carl Zeiss Ltd., Cambridge, UK).
Longitudinal and transverse cell diameter was assessed by
measuring 25 cells in each image using commercially avail-
able software (ImageJ) and obtaining the mean. Experiments
were performed in triplicate, where each experimental
repeat represented a separate isolation from an individual
cat. Statistical significance was evaluated by one-way analysis
of variance (ANOVA) with post-hoc Dunnet’s test. Statistical
analyses were performed using GraphPad Prism software
version 6.0 (Graphpad Software, La Jolla, CA).
Table 1 Primary antibodies used for immunofluorescence and western blotting
Antibody Supplier Secondary antibody Dilution for IF Dilution for western blot Incubation temperature for western blot
Cytokeratin AE1/AE3 Dako Mouse 1:100 1:1000 4 °C
Vimentin
(V9)
Dako Mouse 1:100 1:1000 4 °C
Desmin
(DE-R-11)
Dako Mouse 1:100 N/A N/A
CD29
(TS2/16)
Bio-rad Mouse 1:100 1:500 4 °C
CD44
(156-3C11)
ABD serotec Rat 1:100 N/A N/A
vWF Dako Rabbit 1:200 1:1000 4 °C
VCAM-1 R&D Mouse 1:100 N/A N/A
Rabbit Polyclonal
Isotype control
Biolegend Rabbit 1:50–1:200 N/A N/A
Mouse IgG1 κ
isotype control
Biolegend Mouse 1:50–1:200 N/A N/A
β-actin
(AC-74)
Sigma-Aldrich Mouse N/A 1:5000 4 °C
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RT-qPCR analysis of gene expression after incubation
with TGF-β1
RNA from cells treated as previously described was ex-
tracted using a column based kit (Genelute™ Mammalian
Total RNA Miniprep Kit, Sigma-Aldrich). Messenger RNA
(mRNA) templates were reverse transcribed to complemen-
tary DNA (cDNA) using a commercially available kit
(Omniscript RT, Qiagen), oligo dT primer (MWG Eurofins)
and 1 U/ml RNaseOUT (Life Tehnologies). Gene expression
was quantified by RT-qPCR in 96-well plates (Framestar™,
Fortitude) using a commercially available SYBR Green Taq
ready mix (SYBR® Green JumpStart™ Taq ReadyMix™,
Sigma-Aldrich), and was performed in a CFX Connect™
Real-Time PCR Detection System (Bio-Rad).
Collagen type 1α1 (Col1α1), Fibronectin, α-SMA, CTGF
and TGF-β1 gene expression was analysed by RT-qPCR
and normalised to GAPDH/RPS7 using primers listed in
Table 2. Experiments were performed in quadruplicate,
where each experimental repeat represented a separate
isolation from an individual cat. Data are expressed as
mean fold change relative to untreated control and statis-
tical significance was evaluated by one-way analysis of
variance (ANOVA) with post-hoc Dunnet’s test. Statistical
analyses were performed using GraphPad Prism software
version 6.0 (Graphpad Software, La Jolla, CA).
Results
Characterisation of feline cortical fibroblast (FCF) cultures
Cultures were successfully established from the kidney
tissue of two cats with normal kidney function (FCF)
and four cats with chronic kidney disease (CKD-FCF).
Initial primary cultures were heterogeneous; however
where the tissue was taken from cats with CKD these
cultures were rapidly dominated by cells of a slender
fusiform morphology within 7 days and after the first pas-
sage the culture was relatively homogenous (Fig. 1a-d).
Cultures from the tissue of cats with normal kidney func-
tion were initially dominated by cells of a cobblestone
morphology, and it took until passage 2 to obtain
homogenous cultures of fusiform cells (Fig. 1e). At lower
cell densities, cells exhibited multi-polar and bi-polar
morphology and were randomly orientated but, at conflu-
ence, all cells exhibited a bi-polar morphology and formed
parallel arrays and whorls. Cells maintained their morph-
ology, and continued to proliferate until passage 4–9 when
they became enlarged and senescent (Fig. 1f).
Cells were further characterised using immunofluores-
cence, with western blots performed on CKD-FCF ly-
sates to confirm specificity of antibodies used. FCF and
CKD/FCF stained uniformly positive for vimentin on
immunocytochemistry (Fig. 2a). The vimentin antibody
also recognised a band of approximate molecular weight
54 kDa in CKD-FCF lysates (Fig. 3a). Both FCF and
CKD-FCF were positive for CD29 by immunofluores-
cence (Fig. 2b). The CD29 antibody recognised a band
of approximate molecular weight 130 kDa via immuno-
blotting (Fig. 3a). FCF/CKD-FCF were positive for CD44
(Fig. 2c), CD44 could not be detected by immunoblot-
ting (data not shown). FCF/CKD-FCF were uniformly
negative for cytokeratin AE1/AE3 by immunofluores-
cence (Fig. 2d), and no cytokeratin protein could be de-
tected in CKD-FCF protein lysates by immunoblotting
(Fig. 3b). A human tubular epithelial cell line (HK-2)
was obtained (CRL-2190, ATCC) and cultured as per the
manufacturer’s protocol for use as a positive control
[22].Both cell types were negative for desmin expression
by immunocytochemistry (Fig. 2f ). Desmin could not be
detected via immunoblotting in CKD-FCF lysates (data
not shown). FCF/CKD-FCF were negative for vWF ex-
pression by immunofluorescence (Fig. 2e), and immuno-
blotting could not detect vWF in CKD-FCF (Fig. 3a).
Human umbilical vein endothelial cells (HUVEC) were
Table 2 Primer sequences
Gene Primer sequence (forward primer first, 5′ to 3′) Amplicon size (bp) GC Content (%) Annealing temp Primer dilution
RPS7a GTCCCAGAAGCCGCACTTTGAC
CTCTTGCCCACAATCTCGCTCG
82 59
59
60.8 1:10
GAPDHa AGTATGATTCCACCCACGGCA
GATCTCGCTCCTGGAAGATGGT
101 5255 64.1 1:10
COL1A1 GAGAGCATGACCGACGGATT
TAGGTGATGTTCTGGGACGC
122 55
55
58.7 1:10
TGFB1b GGAATGGCTGTCCTTTGATG
TGCAGTGTGTTATCTTTGCTGTC
120 50
43.5
60 1:10
CTGF GGAAGACACATTTGGCCCAG
GCTTCTCCAACCTGCAGAAG
146 55
55
62.1 1:10
FN1 CCCTCACCAATCTCACTCCA
CCCTCGGAACATCAGAAACTG
117 55
52.4
58 1:10
aPrimer obtained from previous publication: Penning et al. [56]
bPrimer obtained from previous publication: Nguyen Van et al. [57]
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Fig. 1 Morphology of cortical fibroblasts isolated from cats with normal kidney function (FCF) and CKD (CKD-FCF). Representative photomicrographs of
FCF. a, b: CKD-FCF 72 h post isolation. In the presence of FBS, randomly orientated fusiform cells proliferate and begin to dominate the culture c: CKD-FCF
7 days post isolation. Prior to the first passage, although the predominating cell type appears fibroblastic, there are still isolated pockets of epithelial cells. d:
CKD-FCF, passage 1: Relatively homogenous monolayers of cells in parallel arrays are present in cultures derived from diseased kidneys e: FCF, passage 1: In
cultures derived from cats with normal kidney function, cultures at passage 1 are still heterogenous and include pockets of epithelial cells. These cultures
are homogenous in nature by passage 2. f: CKD-FCF, passage 5: After 4–9 passages, cells developed replicative senescence and underwent a change in
morphology. Images were collected using a DMIRB inverted microscope with samples illuminated using an EBQ100 light source (Leica Microsystems,
Milton Keynes, UK) and an AxioCam ICm1 monochrome camera controlled through Axiovision software version 4.8.2 (Carl Zeiss Ltd., Cambridge, UK)
Fig. 2 Immunofluorescence studies of feline cortical fibroblasts isolated from healthy (FCF) and diseased kidneys (CKD-FCF). Immunofluorescence
staining of FCF and CKD-FCF. Cell nuclei were stained with DAPI (blue). Both CKD-FCF and FCF stained positive for the mesenchymal markers vimentin
(a), CD29 (b) and CD44 (c), and were negative for the epithelial marker cytokeratin AE1/AE3 (d), endothelial cell marker vWF (e), and the myogenic
marker desmin (f) (images from CKD-FCF shown). CKD-FCF demonstrated VCAM-1 expression (g) in addition to this, but FCF isolated from the kidneys
of healthy cats did not (h). Isotype controls were negative (i). Images were collected using a DM4000B upright microscope with samples illuminated
using an EBQ100 light source and filter cubes A4 and L5 (all from Leica Microsystems) and an AxioCam MRm monochrome camera controlled through
Axiovision software version 4.8.2 (Carl Zeiss Ltd). Images are representative of cells isolated from 3 different cats (CKD-FCF) and 2 different cats (FCF)
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used as a positive control. Human umbilical cord collec-
tion (obtained with informed written consent) con-
formed to the principles outlined in the Declaration of
Helsinki and is approved by the NHS Health Research
Authority East of England-Cambridge South Research
Ethics Committee (REC reference 16/EE/0396). HUVEC
were isolated and cultured as described previously and
were used at passage 2 [23]. CKD-FCF were positive
(Fig. 2g) whilst FCF were negative for VCAM-1 on
immunofluorescence (Fig. 2h). VCAM-1 could not be
detected by immunoblotting in cell culture lysates or a
positive control consisting of activated endothelial cells
(data not shown). A summary of marker expression for
both cell types can be found in Table 3.
Response of CKD-FCF to incubation with TGF-β1
Experiments to assess the morphological and transcrip-
tional response to TGF-β1 were performed on CKD-FCF
only, as there were insufficient FCF isolations available
to obtain statistical significance. TGF-β1 incubation
resulted in alterations in CKD-FCF cell morphology,
with a concentration dependent hypertrophic effect evi-
dent (Fig. 4). Incubation with 1 ng/ml TGF-β1 for 72 h
resulted in an increase in mean cell longitudinal diam-
eter, and incubation with 10 ng/ml TGF-β1 resulted in
increases in both mean cell longitudinal and transverse
diameter (Fig. 5). All morphological changes were
abrogated by the addition of 5 μM SB431542.
There were no significant changes in target gene
expression after incubation with 0.1 ng/ml TGF-β1 for
72 h. Incubation with 1 ng/ml of TGF-β1 for 72 h
resulted in significant increases in α-SMA (P = 0.044),
fibronectin (P = 0.0199), and CTGF expression (P = 0.0272).
The higher concentration of 10 ng/ml TGF-β1 induced
increased expression of fibronectin (P = 0.01) collagen type
1α1 (P = 0.0145) and TGF-β1 (P = 0.0109) after 72 h
(Fig. 6a-e). In the presence of 5 μM SB431542, alterations
in gene expression induced by 10 ng/ml of TGF-β1 were
completely inhibited.
Discussion
This study describes a simple protocol for the successful
culture of cortical fibroblasts from the kidneys of cats
with normal kidney function, and cats with chronic
kidney disease. To the author’s knowledge, this is the
first study to describe feline renal fibroblasts in culture,
although previously methodology has been published for
the isolation and characterisation of these cells from a
number of other species, including the rabbit [24], rat
[25], mouse [26], and human [27]. It has been recog-
nised since the earliest days of tissue culture that, in the
absence of defined serum-free medium, fibroblasts will
proliferate and overgrow cultures of epithelial cells [28].
This phenomenon was used to obtain cultures of feline
fibroblasts by seeding the sieved cortical tubulointersti-
tial cell fraction into medium containing 10% foetal
bovine serum, a method used previously to obtain fibro-
blasts from human kidneys [27]. Using tissue from cats
with CKD, these cultures were almost completely
Fig. 3 Western blots of CKD-FCF lysates. Immunoblots of CKD-FCF protein lysates from 3 separate isolations. a. CKD-FCF show strong expression
of the mesenchymal marker vimentin and weaker expression of the mesenchymal marker CD29. There was no expression of the endothelial
marker vWF. Human endothelial cell lysate (HAEC) was used as a positive control. b. CKD-FCF do not express the epithelial marker cytokeratin
AE1/AE3. Lysates of human tubular epithelial cells (HK-2) were used as a positive control
Table 3 Summary of marker expression in isolated feline cells
and cell lines
Marker FCF CKD-FCF
Cytokeratin (AE1/AE3) – –
Vimentin + +
Desmin – –
vWF – –
CD29 + +
CD44 + +
VCAM-1 – +
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dominated by cells of a fibroblastic morphology by
passage one, whereas in cats with normal kidney function
this did not occur until passage two. This discrepancy is
probably due to the number of resident fibroblasts present
in the initial tissue; in normal cats the interstitial expres-
sion of fibroblast/myofibroblast markers is low, but
expression increases in cats with CKD [8, 15].
The renal fibroblast population in situ is recognised to
be heterogeneous, with a number of diverse functions,
and is historically not well defined [29, 30]. Collagen
expressing cells surrounding arteries and venules are
known as perivascular fibroblasts, and those closely
associated with peritubular capillaries via pedicle like
attachment plaques are known as pericytes [31]. There
are no markers which exclusively and specifically label
all fibroblasts [29, 32], and differentiating between sub-
populations remains challenging. There is confusion in
the field regarding the precise identity and function of
renal fibroblasts, and in the present study a pragmatic
definition of renal fibroblasts was taken, based on a recent
review, as “nonvascular, nonepithelial, and noninflammatory
cell constituents of the kidney tubulointerstitium” [30]. The
isolated FCF/CKD-FCF in the present study demonstrated
an expression profile similar to that previously reported for
renal fibroblasts from other species, namely positive for the
mesenchymal markers vimentin, CD44 (a transmembrane
adhesion glycoprotein) and CD29 (β1 integrin), and negative
for the epithelial marker cytokeratin, mesangial cell marker
desmin and endothelial cell marker vWF [27, 33, 34].
Vimentin is the major intermediate filament protein of mes-
enchymal cells [35], and has previously been used as a fibro-
blast marker in the normal feline kidney [15]. The
transmembrane proteins CD44 and CD29 have also previ-
ously been shown to label almost 100% of feline dermal
fibroblasts [36]. The CKD-FCF expressed vascular cell
adhesion molecule 1 (VCAM-1), whereas FCF were
negative for this marker. VCAM-1 is an adhesion
molecule of the immunoglobulin superfamily normally
Fig. 4 Representative example of the morphological changes in CKD-FCF after 72 h incubation with TGF-β1. Representative photomicrographs of
CKD-FCF cells after incubation with 0–10 ng/ml TGF-β1 for 72 h. The CKD-FCF underwent dose-dependent morphological changes, becoming
hypertrophic and elongatedThese alterations were inhibited by 5 μM of the TGF-β1R1 antagonist SB431542. Images were collected using a DMIRB
inverted microscope with samples illuminated using an EBQ100 light source (Leica Microsystems) and an AxioCam ICm1 monochrome camera
controlled through Axiovision software version 4.8.2 (Carl Zeiss Ltd)
Fig. 5 Transverse and Longitudinal diameter of CKD-FCF after 72 h incubation with TGF-β1. Transverse and longitudinal diameter of CKD-FCF cells
was assessed after incubation with TGF-β1 (0.1 to 10 ng/ml). There was a significant increase in mean cell longitudinal diameter after incubation
with 1 ng/ml TGF-β1, and increases in both mean cell longitudinal and transverse diameter after incubation with 10 ng/ml TGF-β1. These
alterations were inhibited by 5 μM of the TGF-β1R1 antagonist SB431542. Data represent three experimental repeats using cells from different cats and
were analysed using the one-way ANOVA with Dunnett’s post-hoc analysis. The columns represent mean length and error bars represent the standard
deviation. **P < 0.01 ***P < 0.001
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expressed on monocytes and endothelial cells, which
can be upregulated in fibroblasts exposed to pro-in-
flammatory cytokines such as TNF-α [37]. The results
in the present study are in accordance with previous
work, where renal fibroblasts in healthy kidneys were
negative for VCAM-1 but those in kidneys associated
with inflammatory infiltrates or fibrosis upregulated
expression of this adhesion molecule [33, 38]. There-
fore, it is possible that the CKD-FCF in the present
study represent fibroblasts in an “activated” state.
Further characterisation of these cells could include
examining expression of marker proteins such as α-
SMA, to determine whether they represent a popula-
tion of myofibroblasts, however this may be unlikely
as myofibroblasts have been reported to have a low
proliferative capacity in vitro [39].
Resident renal fibroblasts are the cell type predomin-
antly responsible for the production of extra-cellular
matrix in renal fibrosis, through differentiation into
myofibroblasts [14]. This differentiation is primarily
Fig. 6 TGF-β1 mediated expression of genes related to myofibroblast induction, ECM production and downstream signalling in CKD-FCF. Expression of
the myofibroblast marker α-SMA, ECM-related genes and downstream mediator mRNA was assessed in the CKD-FCF by RT-qPCR after incubation with
TGF-β1 (0.1 to 10 ng/ml). Target gene mRNA copy number was normalised to GAPDH/RPS7 and is expressed as fold change in relation to control. There
were significant increases in collagen type 1α1 expression (a), fibronectin expression (b), α-SMA expression (c), TGF-β1 expression (d) and CTGF expression
(e). There were no significant changes in gene expression when cells were incubated with 10 ng/ml TGF-β1 in the presence of 5 μM SB431542. Data
represent four experimental repeats using cells from different cats and were analysed using the one-way ANOVA with Dunnett’s post-hoc analysis. The
columns represent the mean normalised mRNA copy number and error bars represent the standard deviation.*P < 0.05 **P < 0.01
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thought to occur subsequent to signalling from injured
tubular epithelial cells, as well as infiltrating mononuclear
cells, via a variety of paracrine cytokines and growth factors
[40, 41]. The morphological features differentiating a myofi-
broblast from a fibroblast are only apparent on electron
microscopy and the contractile protein α-SMA is the most
widely used marker of myofibroblast differentiation. This
protein is associated with the role of the myofibroblast in
tissue contraction and interstitial α-SMA expression has
been demonstrated to be upregulated in the renal intersti-
tium of cats with CKD [15]. In the present study, mRNA
expression of α-SMA in CKD-FCF was significantly upregu-
lated by incubation with 1 ng/ml TGF-β1, suggesting an
activation of these cells towards the myofibroblast pheno-
type. Treated cells also exhibited a concentration-dependent
cellular hypertrophy in response to TGF-β1, which has been
noted in previous studies and may also be associated with
an activated phenotype [42]. This result is in agreement with
previous in vitro studies utilising fibroblasts from other
species, where TGF-β1 is well characterised as a mediator of
fibroblast to myofibroblast transition [43].
The upregulation of α-SMA mRNA expression in the
fibroblasts was accompanied by increased collagen type
1α1 and fibronectin mRNA expression, which is a fea-
ture consistent with the myofibroblast phenotype. Colla-
gen type I is the main structural element of the normal
cortical interstitial matrix, and has been demonstrated to
accumulate in increased quantities in the interstitium of
cats with CKD, where it is the predominant collagen
isoform [44, 45]. TGF-β1 has been shown to directly
upregulate collagen transcription in fibroblasts isolated
from other species [46, 47], and it would appear that
TGF-β1 can also be considered a potent inducer of
collagen type I transcription in feline renal fibroblasts.
Fibronectin is a large, adhesive glycoprotein, which ap-
pears early on in the fibrotic process where it is thought
to form a scaffold for the deposition of other ECM pro-
teins and acts as a fibroblast chemoattractant [7]. Fibro-
nectin has previously been reported to be present in
increased quantities in the renal interstitium of cats with
chronic kidney disease [8]. The source of fibronectin in
experimental models of renal disease has been shown to
be interstitial myofibroblasts [48], and fibronectin has
also been correlated with α-SMA expression in cats [8].
In vitro, TGF-β1 has previously been reported to induce
fibronectin production from fibroblasts derived from
other species [47], and the results of the present study
suggest TGF-β1 may be involved in the production of fi-
bronectin by myofibroblasts in feline kidney disease also.
Treatment with recombinant TGF-β1 protein resulted
in auto-induction of TGF-β1 mRNA. This phenomenon
has been documented previously, and is thought to be
important in amplifying and sustaining the effects of
TGF-β1 via an autocrine loop [49]. Incubation with
1 ng/ml TGF-β1 also resulted in increased in CTGF
mRNA expression. CTGF is a member of the CCN family
of matricellular proteins, a group which plays an import-
ant role in tissue homeostasis, wound healing and repair
via mediation of ECM-cell crosstalk and modulation of
growth factor activity [50]. CTGF is thought to be an im-
portant downstream mediator of the pro-fibrotic effects of
TGF-β1, particularly myofibroblast activation and ECM
production [50, 51]. The current study suggests CTGF
may also be involved in TGF-β1 mediated fibrogenesis in
the feline kidney as in other species, although further
work is needed to demonstrate a causative role.
The canonical TGF-β1 signalling pathway involves TGF-
β1 binding to the TGF-β1 type II receptor (TGF-β1RII),
which recruits the TGF-β1 type I receptor (TGF-β1RI, also
known as activin-like kinase 5 [ALK-5]) and forms a het-
eromeric receptor complex which phosphorylates receptor
regulated Smad proteins (Smad2 and Smad3) [52]. These
proteins then go on to regulate the transcription of target
genes in the nucleus. TGF-β1-induced collagen production
has been reported to be dependent on TGF-β1RII in renal
interstitial matrix-producing cells, both in vitro and in vivo
[53]. In the present study, the small molecule TGF-β1RI
antagonist SB431542 was found to inhibit the pro-fibrotic
effects of TGF-β1 on CKD-FCF at the mRNA level. This
finding is in agreement with previous work on renal fibro-
blasts derived from rodents, and indicates that the effects
of TGF-β1 on fibroblasts are mediated by the TGF-
β1RI(ALK5)/TGF-β1RII receptor complex in cats as in
other species [54].
There were several limitations to the current study, most
significantly, the small number of cats included. It is
possible that the conclusions drawn regarding cell marker
expression were skewed due to the small number of isola-
tions, and further investigation utilising a larger population
of cats is required to support the findings of this study.
There was particular difficulty in obtaining kidney tissue
from cats with normal kidney function, and deriving FCF
cells from this tissue. Therefore it was not possible to
obtain enough FCF to perform TGF-β1 stimulation experi-
ments on this cell type. It is possible that fibroblasts from
diseased kidneys have a heightened sensitivity to TGF-β1,
and enhanced coupling to pathways regulating gene expres-
sion, but a definitive demonstration of this is currently not
possible. Further work to isolate larger numbers of FCF
would enable direct comparison of data between FCF and
CKD-FCF, and potentially provide new insights into the
pathology of feline CKD.
A further limitation was that the CKD-FCF were
obtained from cats of different ages and, furthermore,
with differing degrees of renal pathology. This diverse
origin is likely responsible for the variability in the be-
haviour of cells from different animals. These factors
were largely unavoidable due to the isolation of these
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cells from pet cats euthanized for welfare reasons (with
owner informed consent). Furthermore recombinant
human TGF-β1 was used in experiments, as feline
TGF-β1 is not commercially available. TGF-β1 is a well-
conserved gene, with 95.1% homology between the human
and feline sequence, which is also true of the TGF-β1RI
gene (92.7% homology) and, to a lesser extent, the TGF-
β1RII gene (83.8%) [55], but receptor-ligand kinetics may
have been affected by this different species of origin. Fur-
thermore, only mRNA expression after incubation with
TGF-β1 was examined, which may not have accurately rep-
resented protein expression. Further work to confirm in-
creased protein expression of the target genes should also
be performed in order to confirm these results. Finally, the
in vitro cell culture environment is significantly different
from the three dimensional kidney architecture, within
which cells reside in complex structures. Therefore, these
results obtained in vitro do need to be translated with
caution into the whole animal.
Conclusions
In conclusion, we have reported a simple methodology for
the isolation of FCF/CKD-FCF from cadaverous kidney
tissue. The cultures described represent an in vitro model
for the investigation of factors and processes relevant to
fibroblast-myofibroblast differentiation, and by extension,
the initiation and progression of renal fibrosis in vivo. FCF
and CKD-FCF appeared phenotypically similar, although
expression of VCAM-1 on CKD-FCF suggested these cells
were in an “activated” state. In addition, TGF-β1 was shown
to induce dose dependent alterations in morphology and
gene expression in CKD-FCF suggestive of myofibroblast
differentiation. These effects were inhibited by the TGF-
β1RI antagonist SB431542, suggesting they are mediated
via the TGF-β1RI (ALK5)/TGF-β1RII receptor complex.
These findings suggest that TGF-β1 may be involved in
fibroblast-myofibroblast transition in feline chronic kidney
disease as in other species.
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